BAUSCH + LOMB CORP

NYSE: BLCO (Bausch + Lomb Corporation)

最近更新时间: 4天之前, 11:33PM

21.09

-0.05 (-0.24%)

前收盘价格 21.14
成交量 524,940
预期市盈率 (P/E Forward) 18.34
价格/销量 (P/S) 1.39
股市价格/股市净资产 (P/B) 1.17
52周波幅
14.44 (-31%) — 21.40 (1%)
营业毛利率 -7.50%
营业利益率 (TTM) -5.36%
稀释每股收益 (EPS TTM) -1.02
季度收入增长率 (YOY) 3.50%
总债务/股东权益 (D/E MRQ) 75.07%
流动比率 (MRQ) 1.56
营业现金流 (OCF TTM) 166.00 M
杠杆自由现金流 (LFCF TTM) 69.00 M
资产报酬率 (ROA TTM) 0.61%
股东权益报酬率 (ROE TTM) -5.36%

AIStockmoo 评分

1.3
来自我们的 AI Insight 报告对预期回报与风险的评估。 参考 NA
相对估值 参考 NA
隐含增长 参考 NA
历史估值 参考 NA
负债低。盈利能力弱。现金流为正。 参考
资本回报 参考 NA
来自我们对走势图的 AI 技术分析。 参考 NA
过去一年没有明确趋势。股价接近52周高点。 参考
上升趋势:股价位于均线之上,均线向上。股价已大幅高于均线。上涨日成交量较大。 参考
K线形态 参考 NA
高于中期趋势线。 参考
近期没有目标价,因此依据目标价的调整方向。 参考
近期新闻大多正面。 参考
内部交易活动 参考 NA
机构在最新13F申报中净-0.28%的股份:60家增持,35家减持(截至30 Sep 2026的季度)。 参考
市场环境偏谨慎。 参考
行业表现优于大市。
各支柱方向一致,评分因此加强。
股价高于其52周平均水平。 参考
短、中、长期趋势均向上。短期动能上升。 参考
股价接近阻力位。 参考
最终评分 1.34
全部展开

市场趋势

短期 中期
行业 Medical Instruments & Supplies (US) 混合的 混合的
Medical Instruments & Supplies (全球的) 混合的 混合的
股票 Bausch + Lomb Corporation 混合的 看涨

相关股票

股票 市值 DY P/E(TTM) P/B
BLCO - - - 1.17
RMD - 1.08% - 5.66
BDX - 2.20% - 2.41
WST - 0.37% - 9.67
ALC - 0.49% - 1.64
STVN - 0.30% - 2.39

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

部门 Healthcare
行业 Medical Instruments & Supplies
投资方式 Mid Core
内部持股比例 88.13%
机构持股比例 10.97%

所有权

姓名 日期 持有股份
Caspian Capital Lp 30 Jun 2026 1,999,043
Glenview Capital Management, Llc 30 Jun 2026 1,918,148
Clark Estates Inc/Ny 30 Sep 2026 881,000

该时间范围内无数据。

该时间范围内无数据。

机构

机构持股比例: 10.66%

持仓变动 机构数 股数
增持 60 5,333,667
减持 35 5,694,076
新建仓 24 1,736,083
清仓 9 2,368,991

来源:经Nasdaq的SEC 13F申报,最新申报截至30 Sep 2026。申报在每季结束后45天内陆续提交。

7 正面 0 负面 2 中性
日期 类型 细节
14 Nov 2026 Yahoo Finance Bausch + Lomb (BLCO) Following Its Rally Is Fair Value Still In Sight
Bausch + Lomb (BLCO) has been drawing attention after recent trading, with the share price last closing at US$21.09. The move sits against a recent pattern of mixed short term and longer term returns. Over the past month, Bausch + Lomb has seen a sharp shift in momentum, with a 31.48% 30 day share…
13 Nov 2026 Yahoo Finance Bausch + Lomb (BLCO) Stock Still Looks Undervalued Despite Its 35% Run
Bausch + Lomb shares have moved higher in recent months, which puts a sharper spotlight on whether the current US$21.09 price lines up with the cash flows the business can realistically generate. After a solid stretch for the stock, the key issue for anyone looking at Bausch + Lomb today is how…
13 Nov 2026 Yahoo Finance Best Growth Stocks to Buy for November 13th
BLCO, VLO, and HAS it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 13, 2026…
11 Nov 2026 Yahoo Finance Best Growth Stocks to Buy for November 11th
BLCO, VLO, and HAS it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 11, 2026…
06 Nov 2026 Yahoo Finance Zacks.com featured highlights include Repsol, Bausch + Lomb, DMC Global, Universal Logistics and Methanex
Repsol, Bausch + Lomb and three other stocks show strong relative price strength, rising earnings estimates and potential for further gains.
05 Nov 2026 Yahoo Finance Are You Looking for a Top Momentum Pick? Why Bausch + Lomb (BLCO) is a Great Choice
Does Bausch + Lomb (BLCO) have what it takes to be a top stock pick for momentum investors? Let's find out.
04 Nov 2026 Yahoo Finance Bausch + Lomb: 3 Key Takeaways for Long-Term Investors
Premium product adoption is lifting margins faster than revenue growth, a sign of pricing power in a competitive market.
04 Nov 2026 Yahoo Finance Why Bausch + Lomb (BLCO) Might be Well Poised for a Surge
Bausch + Lomb (BLCO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
03 Nov 2026 Yahoo Finance BLCO vs. HQY: Which Stock Is the Better Value Option?
BLCO vs. HQY: Which Stock Is the Better Value Option?

技术形态 中期

趋势排列
斜率
入场位置
成交量
上升趋势:股价位于均线之上,均线向上。股价已大幅高于均线。上涨日成交量较大。
最近支撑: 19.36 – 19.84 · 中等
最近阻力: 21.20 – 21.56 · 中等

AI 技术分析

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2026 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票